Growth hormone-releasing peptides are so poorly studied, we often do not know how they get metabolized in the body and thus which molecules to look for
Slow Responders (15-20% of users): May not notice meaningful changes until week 3 or 4, with peak benefit reached around week 8 to 10
Standard oral dosage Ideal For Individuals seeking gut health optimization, digestive support, systemic healing benefits, or those preferring non-injectable therapy under medical guidance
A prescriber may write a prescription in Units or in mLs
The peptide is still in the early stages of animal studies
GLP-3 (Reta) Research Applications GIP, GLP-1 and glucagon receptor binding and cAMP-accumulation assays in cells co-expressing the three receptors, where GLP-3 (Reta) is the standard reference triple agonist